News

People with a certain heart valve abnormality are at increased risk of severe heart rhythm disorders, even after successful valve surgery. This is according to a new study, "Mitral annular disjunction ...
People with a certain heart valve abnormality are at increased risk of severe heart rhythm disorders, even after successful valve surgery. This is ...
People with a certain heart valve abnormality are at increased risk of severe heart rhythm disorders, even after successful valve surgery. This is ...
Edwards Lifesciences Corp.’s Sapien M3 secured CE mark for its Sapien M3 mitral valve replacement system for transfemoral treatment of patients with mitral valve disease who are ineligible for surgery ...
The Irvine-based medical device maker today announced that it received CE mark approval for its Sapien M3 mitral replacement ...
Edwards Lifesciences has received CE marking for its transfemoral transcatheter mitral valve replacement system, setting up ...
Edwards Lifesciences (EW) announced the company’s Sapien M3 mitral valve replacement system received CE Mark for the transcatheter treatment of ...
Edwards Lifesciences (NYSE:EW) announced today that it received CE mark approval for its Sapien M3 mitral valve replacement ...
The following is a summary of "Novel Right Ventricular Function Parameters Can Identify Short-Term Non-Responders To ...
Edwards Lifesciences Corporation (NYSE: EW) today announced the company’s SAPIEN M3 mitral valve replacement system received ...